Quadrant Private Wealth Management LLC decreased its holdings in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 3.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,995 shares of the company’s stock after selling 1,000 shares during the period. Tabula Rasa HealthCare comprises approximately 2.1% of Quadrant Private Wealth Management LLC’s investment portfolio, making the stock its 12th largest holding. Quadrant Private Wealth Management LLC owned approximately 0.15% of Tabula Rasa HealthCare worth $1,976,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. First Mercantile Trust Co. purchased a new position in Tabula Rasa HealthCare in the 4th quarter valued at $39,000. TCI Wealth Advisors Inc. raised its holdings in shares of Tabula Rasa HealthCare by 1,600.0% during the 4th quarter. TCI Wealth Advisors Inc. now owns 850 shares of the company’s stock worth $54,000 after acquiring an additional 800 shares during the period. Quantamental Technologies LLC purchased a new position in shares of Tabula Rasa HealthCare during the 4th quarter worth $64,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Tabula Rasa HealthCare during the 4th quarter worth $135,000. Finally, LS Investment Advisors LLC raised its holdings in shares of Tabula Rasa HealthCare by 19.9% during the 4th quarter. LS Investment Advisors LLC now owns 2,813 shares of the company’s stock worth $179,000 after acquiring an additional 466 shares during the period. Hedge funds and other institutional investors own 79.23% of the company’s stock.
TRHC stock opened at $52.81 on Monday. Tabula Rasa HealthCare Inc has a 1 year low of $28.55 and a 1 year high of $91.16. The company has a quick ratio of 0.46, a current ratio of 0.49 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $1.08 billion, a PE ratio of -1,320.25, a P/E/G ratio of 3.35 and a beta of 1.79.
Several research analysts have recently commented on the company. Zacks Investment Research lowered Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a report on Saturday, November 10th. BidaskClub downgraded Tabula Rasa HealthCare from a “sell” rating to a “strong sell” rating in a research report on Saturday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $82.27.
In other Tabula Rasa HealthCare news, CFO Brian W. Adams sold 684 shares of Tabula Rasa HealthCare stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $41,040.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction on Monday, November 19th. The shares were sold at an average price of $61.68, for a total value of $493,440.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 57,790 shares of company stock valued at $3,821,870. 14.00% of the stock is owned by insiders.
WARNING: This piece was first published by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.fairfieldcurrent.com/news/2019/02/11/tabula-rasa-healthcare-inc-trhc-stake-lessened-by-quadrant-private-wealth-management-llc.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Further Reading: Benefits of owning preferred stock
Receive News & Ratings for Tabula Rasa HealthCare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com’s FREE daily email newsletter.